Cargando…

Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases

BACKGROUND: Aggressive hepatectomy with venous resection has a higher risk of postoperative liver failure (POLF) than hepatectomy without venous reconstruction; however, venous reconstruction is technically demanding. We performed a novel two-stage hepatectomy (TSH) without venous reconstruction in...

Descripción completa

Detalles Bibliográficos
Autores principales: Maki, Harufumi, Satou, Shouichi, Nakajima, Kentaro, Nagao, Atsuki, Watanabe, Kazuteru, Satodate, Hitoshi, Nara, Satoshi, Furushima, Kaoru, Harihara, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815977/
https://www.ncbi.nlm.nih.gov/pubmed/29453737
http://dx.doi.org/10.1186/s40792-018-0424-5
_version_ 1783300587631149056
author Maki, Harufumi
Satou, Shouichi
Nakajima, Kentaro
Nagao, Atsuki
Watanabe, Kazuteru
Satodate, Hitoshi
Nara, Satoshi
Furushima, Kaoru
Harihara, Yasushi
author_facet Maki, Harufumi
Satou, Shouichi
Nakajima, Kentaro
Nagao, Atsuki
Watanabe, Kazuteru
Satodate, Hitoshi
Nara, Satoshi
Furushima, Kaoru
Harihara, Yasushi
author_sort Maki, Harufumi
collection PubMed
description BACKGROUND: Aggressive hepatectomy with venous resection has a higher risk of postoperative liver failure (POLF) than hepatectomy without venous reconstruction; however, venous reconstruction is technically demanding. We performed a novel two-stage hepatectomy (TSH) without venous reconstruction in a patient with bilobar multiple colorectal liver metastases located near the caval confluence, waiting for the development of intrahepatic venous collaterals between procedures. CASE PRESENTATION: A 60-year-old man was referred to our hospital with sigmoid colon cancer accompanied by intraabdominal abscess and two synchronous liver metastases. One of the liver tumors (tumor 1) was located in segment 8 near the caval confluence and was attached to both the right hepatic vein (RHV) and middle hepatic vein (MHV). The other tumor (tumor 2) in the left lobe invaded the umbilical portion of the portal vein. Both liver metastases decreased in size after four cycles of panitumumab/5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) therapy. Radical liver resection was planned because tumor 1 had not invaded the MHV. However, three-dimensional volumetric software showed that the non-congested volume of the future liver remnant was estimated at 354 ml, which corresponded to 26.3% of the total liver volume. TSH was scheduled to avoid POLF. We first performed limited resection of segment 8 with resection of the RHV root. After the first hepatectomy, the development of intrahepatic venous collaterals between the RHV and MHV was seen on computed tomography and magnetic resonance imaging. The estimated non-congested future liver remnant was 1242 ml, 78.5% of the total liver volume. Therefore, the patient underwent left hemihepatectomy 58 days after the first hepatectomy. We saw no adhesions around the porta hepatis, and the left hepatic artery and left branch of the portal vein were safely exposed and divided. Intraoperative Doppler ultrasonography revealed intrahepatic venous collaterals arising from RHV to MHV. The patient’s postoperative course was uneventful, and he underwent eight cycles of panitumumab/FOLFOX therapy for 5 months after the second hepatectomy. CONCLUSIONS: Our TSH strategy helped avoid POLF by waiting for the development of intrahepatic venous collaterals.
format Online
Article
Text
id pubmed-5815977
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58159772018-02-27 Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases Maki, Harufumi Satou, Shouichi Nakajima, Kentaro Nagao, Atsuki Watanabe, Kazuteru Satodate, Hitoshi Nara, Satoshi Furushima, Kaoru Harihara, Yasushi Surg Case Rep Case Report BACKGROUND: Aggressive hepatectomy with venous resection has a higher risk of postoperative liver failure (POLF) than hepatectomy without venous reconstruction; however, venous reconstruction is technically demanding. We performed a novel two-stage hepatectomy (TSH) without venous reconstruction in a patient with bilobar multiple colorectal liver metastases located near the caval confluence, waiting for the development of intrahepatic venous collaterals between procedures. CASE PRESENTATION: A 60-year-old man was referred to our hospital with sigmoid colon cancer accompanied by intraabdominal abscess and two synchronous liver metastases. One of the liver tumors (tumor 1) was located in segment 8 near the caval confluence and was attached to both the right hepatic vein (RHV) and middle hepatic vein (MHV). The other tumor (tumor 2) in the left lobe invaded the umbilical portion of the portal vein. Both liver metastases decreased in size after four cycles of panitumumab/5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) therapy. Radical liver resection was planned because tumor 1 had not invaded the MHV. However, three-dimensional volumetric software showed that the non-congested volume of the future liver remnant was estimated at 354 ml, which corresponded to 26.3% of the total liver volume. TSH was scheduled to avoid POLF. We first performed limited resection of segment 8 with resection of the RHV root. After the first hepatectomy, the development of intrahepatic venous collaterals between the RHV and MHV was seen on computed tomography and magnetic resonance imaging. The estimated non-congested future liver remnant was 1242 ml, 78.5% of the total liver volume. Therefore, the patient underwent left hemihepatectomy 58 days after the first hepatectomy. We saw no adhesions around the porta hepatis, and the left hepatic artery and left branch of the portal vein were safely exposed and divided. Intraoperative Doppler ultrasonography revealed intrahepatic venous collaterals arising from RHV to MHV. The patient’s postoperative course was uneventful, and he underwent eight cycles of panitumumab/FOLFOX therapy for 5 months after the second hepatectomy. CONCLUSIONS: Our TSH strategy helped avoid POLF by waiting for the development of intrahepatic venous collaterals. Springer Berlin Heidelberg 2018-02-16 /pmc/articles/PMC5815977/ /pubmed/29453737 http://dx.doi.org/10.1186/s40792-018-0424-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Maki, Harufumi
Satou, Shouichi
Nakajima, Kentaro
Nagao, Atsuki
Watanabe, Kazuteru
Satodate, Hitoshi
Nara, Satoshi
Furushima, Kaoru
Harihara, Yasushi
Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
title Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
title_full Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
title_fullStr Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
title_full_unstemmed Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
title_short Two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
title_sort two-stage hepatectomy aiming for the development of intrahepatic venous collaterals for multiple colorectal liver metastases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815977/
https://www.ncbi.nlm.nih.gov/pubmed/29453737
http://dx.doi.org/10.1186/s40792-018-0424-5
work_keys_str_mv AT makiharufumi twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT satoushouichi twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT nakajimakentaro twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT nagaoatsuki twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT watanabekazuteru twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT satodatehitoshi twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT narasatoshi twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT furushimakaoru twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases
AT hariharayasushi twostagehepatectomyaimingforthedevelopmentofintrahepaticvenouscollateralsformultiplecolorectallivermetastases